Europe — EMA

Ondansetron Viatris

Ondondansetron, the active ingredient in Ondansetron Viatris, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for unknown use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron Viatris, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for unknown use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adults and children.

GNH USA supplies Ondansetron Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Ondansetron used for?

Ondansetron is a selective 5‑HT3 receptor antagonist that ... - C .... .... .... ...........................

What are the side effects of Ondansetron?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →